Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 42: 536-544, 1996;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffman, B. R.
Right arrow Articles by Diamandis, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffman, B. R.
Right arrow Articles by Diamandis, E. P.

Clinical Chemistry, Vol 42, 536-544, Copyright © 1996 by American Association for Clinical Chemistry

Assay of prostate-specific antigen from whole blood spotted on filter paper and application to prostate cancer screening

BR Hoffman, H Yu and EP Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.

We report the measure of prostate-specific antigen (PSA) from extracts of blood dried on filter paper. Five 3-mm (diameter) paper discs containing approximately 25 microL of dried whole blood were punched from the filter paper and extracted with 500 microL of buffer. Recovery of PSA was > 92%. Imprecision of the filter paper procedure was <10% when corresponding whole-blood concentrations were >0.35 micrograms/L. PSA recovery was unaffected whether blood was applied to the filter as one 85-microL aliquots, two 43-microL aliquots, or three 28-microL aliquots. PSA is contained in the plasma fraction. Variation in hematocrit from 0.61 to 0.31 caused <+/-10% change in filter paper PSA. Regression analysis showed: filter paper PSA = 0.86 whole-blood PSA - 0.02; Sy/x = 0.44. Men (153) without prostate cancer gave a 95th percentile of 4.8 micrograms /L. PSA in filter paper dried blood was stable for >1 month at -20 to 37 degrees C and showed no loss of recovery after being mailed to a hot climate. We conclude that the filter paper procedure can reliably distinguish normal from increased concentrations of PSA and that it could facilitate screening to detect occult prostate cancer in large-scale mail-in programs to centralized laboratories.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
M. I. L. Sjoholm, J. Dillner, and J. Carlson
Assessing Quality and Functionality of DNA from Fresh and Archival Dried Blood Spots and Recommendations for Quality Control Guidelines
Clin. Chem., August 1, 2007; 53(8): 1401 - 1407.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. R. Grzeda, T. Le Bui, C. N. Warner, T. L. Pirucki, L. M. Dewey, M. Babich, and J. A. Maggiore
Measurement of Prostate-specific Antigen by Use of a Novel Blood Collection and Analytical System
Clin. Chem., August 1, 2002; 48(8): 1272 - 1278.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Khosravi and A. Diamandi
Dried Blood Spot Assay of Insulin-Like Growth Factor (IGF)-I and IGF Binding Protein-3 (IGFBP-3)--Authors' Response
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 822a - 823.
[Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Diamandi, M. J. Khosravi, J. Mistry, V. Martinez, and J. Guevara-Aguirre
Filter Paper Blood Spot Assay of Human Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-3 and Preliminary Application in the Evaluation of Growth Hormone Status
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2296 - 2301.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Association for Clinical Chemistry.